# Study Targeting Affect Regulation

> **NCT01237366** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 56 (actual)

## Conditions studied

- HIV
- AIDS
- Substance Use Disorders

## Interventions

- **BEHAVIORAL:** Resilient Affective Processing Therapy (RAPT)

## Key facts

- **NCT ID:** NCT01237366
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-01
- **Final completion:** 2014-05
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2014-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01237366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01237366, "Study Targeting Affect Regulation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01237366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*